ABC | Volume 112, Nº2, February 2019

Review Article Fontes-Carvalho et al The Year in Cardiology 2018: ABC Cardiol and RPC at a glance Arq Bras Cardiol. 2019; 112(2):193-200 the patient delay to primary angioplasty in myocardial infarction with ST- segment elevation (STEMI): The Stent for life initiative in Portugal. Rev Port Cardiol. 2018; 37(5):409-21. 8. Nallamothu BK, Normand SL, Wang Y, Hofer TP, Brush JE Jr, Messenger JC, et al. Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study. Lancet. 2015;385(9973):1114-22. 9. De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109(10):1223-5. 10. De Luca G, Suryapranata H, Zijlstra F, van ‘t Hof AW, Hoorntje JC, Gosselink AT, et al. Symptom-onset-toballoon time andmortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol. 2003;42(6):991-7. 11. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2018 Aug 25 [ahead of print] 12. Davies JE, Sen S, Dehbi HM, Al-Lamee R, Petraco R, Nijjer SS,et al.Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. N Engl J Med .2017;376(19):1824–34. 13. Gotberg M, Christiansen EH, Gudmundsdottir IJ, Sandhall L, Danielewicz M, Jakobsen L, et al. iFRSWEDEHEART Investigators. Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. N Engl J Med .2017;376(19)1813–23. 14. CookCM,JeremiasA,PetracoR,SenS,NijjerS,Shun-ShinMJ,etal.Fractional flow reserve/instantaneous wave-free ratio discordance in angiographically intermediate coronary stenoses: an analysis using Doppler-derived coronary flowmeasurements. JACC Cardiovasc Interv. 2017;10(24):2514-24. 15. Menezes MN, Francisco AR, Ferreira PC, Jorge C, Torres D, Cardoso P, et al. Comparative analysis of fractional flow reserve and instantaneous wave-free ratio: Results of a five-year registry. Rev Port Cardiol. 2018;37(6):511-20. 16. Lee JM, Shin ES, NamCW, Doh JH, Hwang D, Park J, et al. Clinical outcomes according to fractional flow reserve or instantaneous wave-free ratio in deferred lesions. JACC Cardiovasc Interv. 2017;10(24):2502-10. 17. Kern MJ, Seto AH. Is instantaneous wave-free ratio a new standard of care for physiologic assessment of coronary lesions?More questions than answers. Circulation. 2017;136(24):2295-7. 18. Bravo Baptista S, Raposo L. Coronary pressure (sometimes) lies. Rev Port Cardiol. 2018;37(6):521-3. 19. Farsky PS, Hirata MH, Arnoni RT, Almeida AFS, Issa M, Lima PH. Persistent inflammatory activity in blood cells and artery tissue from patients with previous bare metal stent. Arq Bras Cardiol. 2018; 111(2):134-41. 20. Borges JM, Almeida PA, NascimentoMM, Barreto Filho JA, Rosa MB, Sousa AC. Factors associated with inadequate management of antiplatelet agents in perioperative period of non- cardiac surgeries. Arq Bras Cardiol.2018; 111(4):596-604. 21. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC guidelines for themanagement of acutemyocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST- segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-77. 22. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients pre-senting without persistent ST-segment elevation. Eur Heart J. 2016;37(3):267-315. 23. DondoTB,HallM,WestRM,JernbergT,LindahlB,BuenoH,etal. β -Blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction. J AmColl Cardiol. 2017;69(22):2710-20. 24. Bangalore S, Steg G, Deedwania P, Crowley K, Eagle KA, Goto S, et al. β -Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13):1340-9. 25. Timóteo AT, Rosa SA, Cruz M, Moreira RI, Carvalho R, Ferreira ML, et al. What is the role of beta-blockers in a contemporary treatment cohort of patients with acute coronary syndromes? A propensity-score matching analysis. Rev Port Cardiol. 2018;37(11):901-8. 26. Silva CG, Klein CH, Godoy PH, Salis LH, Silva NA. Up to 15-year survival of men and women after percutaneous coronary intervention paid by the brazilian public healthcare system in the state of Rio de Janeiro, 1999-2010. Arq Bras Cardiol. 2018;111(4):553-61. 27. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-962. 28. Andersson T, Magnuson A, Bryngelsson IL, Frobert O, Henriksson KM, EdvardssonN, et al. All-causemortality in 272,186 patients hospitalizedwith incident atrial fibrillation 1995-2008: a Swedish nationwide long-termcase control study. Eur Heart J. 2013;34(14):1061-7. 29. Monteiro P. Emnome dos Investigadores do Estudo Safira. The SAFIRA study: A reflection on the prevalence and treatment patterns of atrial fibrillation and cardiovascular risk factors in 7500 elderly subjects. Rev Port Cardiol. 2018;37(4):307-13. 30. Bonhorst D, Mendes M, Adragão P, De Sousa J, Primo J, Leiria E, et al. Prevalence of atrial fibrillation in the Portuguese population aged 40 and over: the FAMA study. Rev Port Cardiol. 2010;29(3):331-50. 31. Primo J, Gonçalves H, Macedo A, Russo P, Monteiro T, Guimarães J, et al. Prevalence of paroxysmal atrial fibrillation in a population assessed by continuous 24-hour monitoring. Rev Port Cardiol. 2017;36(7-8):535-46. 32. Freedman B, Camm J, Calkins H; AF-Screen Collaborators. Screening for atrial fibrillation: A report of the AF-SCREEN international collaboration. Circulation. 2017;135(19):1851-67. 33. Stephan LS, Almeida ED, Guimarães RB, Ley AG, Mathias RG, Assis MV, et al. Oral anticoagulation in atrial fibrillation: development and evaluation of a mobile health application to support shared decision-making. Arq Bras Cardiol. 2018;110(1):7-15. 34. Biro FM, WienM. Childhood obesity and adult morbidities. Am J Clin Nutr. 2010;91(5):1499S-1505S. 35. Williams CL, Hayman LL, Daniels SR, Robinson TN, Steinberger J, Paridon S, et al.Cardiovascularhealth in childhood: astatement forhealthprofessionals from the committee on atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the council on cardiovascular disease in the young, American Heart Association. Circulation. 2002;106(1):143-60. 36. Peñalvo JL, Santos-Beneit G, Sotos-Prieto M, Bodega P, Oliva B, Orrit X, et al. The SI! Program for cardiovascular health promotion in early childhood: a cluster-randomized trial. J Am Coll Cardiol. 2015;66(14):1525–34. 37. Vedanthan R, Bansilal S, Soto AV, Kovacic JC, Latina J, JaslowR, et al. Family- based approaches to cardiovascular health promotion. J Am Coll Cardiol. 2016;67(14):1725-37. 38. Rodrigues PR, Pereira RA, Gama A, Carvalhal IM, Nogueira H, Rosado- Marques V, et al. Body adiposity is associatedwith risk of high blood pressure in Portuguese schoolchildren. Rev Port Cardiol. 2018;37(4):285-92. 39. Boelsen-Robinson T, Gearon E, Peeters A. Incidence of childhood obesity in the United States. N Engl J Med. 2014; 370(17):403-11. 40. Fuster V. Stratified approach to health: integration of science and education at the right time for each individual. J AmColl Cardiol. 2015;66(14):1627-9. 41. Safeer RS, Cooke CE, Keenan J. The impact of health literacy on cardiovascular disease. Vasc Health Risk Manag. 2006;2(4):457-64. 42. Andrade N, Alves E, Costa AR, Moura-Ferreira P, Azevedo A, Lunet N. Knowledge about cardiovascular disease in Portugal. Rev Port Cardiol. 2018;37(8):669-78. 43. PereiraH,PintoFJ, CaléR,PereiraE,Marques J,AlmeidaM,etal.Stent for life inPortugal:this initiative isheretostay.RevPortCardiol.2014;33(6):363-70. 44. Cardim N, Brito D, Rocha LL, Freitas A, Araújo C, Belo A, et al. The portuguese registry of hypertrophic cardiomyopathy: Overall results. Rev Port Cardiol. 2018;37(1):1-10. 199